FDA product code QXC: Diabetes Digital Therapeutic Device

QXC is the FDA product code for diabetes digital therapeutic device. It is a Class II device, regulated under 21 CFR 880.5735 and reviewed by the Clinical Chemistry panel. Devices under QXC reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A diabetes digital behavioral therapeutic device is a prescription use software device that provides digital behavioral therapy to aid in the management of diabetes. This device is intended to provide limited secondary benefit to patients with diabetes mellitus by assisting them in managing their condition. This device is not intended to replace any primary treatment, such as diet/lifestyle changes or medication.

Classification

FieldValue
Device nameDiabetes Digital Therapeutic Device
Device classClass II
Regulation21 CFR 880.5735
Review panelCH — Clinical Chemistry
Medical specialtyGeneral Hospital
Premarket route510(k)

Recalls for QXC devices

FDA recall records list no recalls for product code QXC.

Frequently asked questions

What is FDA product code QXC?

QXC is the FDA product code for diabetes digital therapeutic device. It is a Class II device, regulated under 21 CFR 880.5735 and reviewed by the Clinical Chemistry panel.

What device class is QXC?

Class II, regulation 21 CFR 880.5735. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times